期刊文献+

肿瘤相关巨噬细胞在癌症治疗的潜在靶点中的探讨 被引量:2

The role of tumor-associated macrophages in the potential target of cancer therapy
下载PDF
导出
摘要 肿瘤的微环境(TME)由肿瘤细胞和周围基质组成,其中巨噬细胞能够促进肿瘤的增殖、侵袭和转移,促进肿瘤血管生成,抑制T细胞介导的抗肿瘤免疫反应,从而导致肿瘤的发生发展。本文阐述了巨噬细胞的形成,从根源上阐述了TAMs如何被用作癌症的治疗靶点,及肿瘤相关巨噬细胞的靶向治疗的抗癌药物的作用机制。以肿瘤相关巨噬细胞(TAMs)表面的标记物作为治疗的靶点或作为抗癌药物的载体进入肿瘤细胞是肿瘤治疗的潜在方法。 The microenvironment(TME) of tumors is composed of tumor cells and surrounding stroma. Macrophages can promote tumor proliferation, invasion and metastasis, promote tumor angiogenesis, and inhibit T cell-mediated anti-tumor immune response, resulting in the occurrence and development of tumors. This article describes the formation of macrophages, describes how TAMs are used as therapeutic targets for cancer from the roots, and reviews the mechanism of anticancer drugs targeted by tumor-associated macrophages. Choosing markers on the surface of tumor-associated macrophages (TAMs) as a therapeutic target or as a carrier of anticancer drugs into tumor cells is a potential method for tumor therapy.
作者 武艳飞 白雪峰 王智 WU Yanfei;BAI Xuefeng;WANG Zhi(Baotou Medical College,Baotou 014030,China;Department of Pathology,Baotou Cancer Hospital in Inner Mongolia Autonomous Region,Baotou 014030,China;Department of Hematology,Bayannaoer Hospital in Inner Mongolia Autonomous Region,Bayannaoer 015001,China)
出处 《中国现代医生》 2019年第4期161-164,168,共5页 China Modern Doctor
关键词 肿瘤微环境 巨噬细胞与肿瘤相关巨噬细胞 靶点 载体 靶向治疗 抗癌药物机制 Tumor microenvironment Macrophage and tumor-associated macrophages Target Vector Targeted therapy Anticancer drug mechanism
  • 相关文献

参考文献2

二级参考文献58

  • 1张有为,邓红,陈平圣,陈露露.成纤维细胞与大肠癌细胞相互作用对大肠癌细胞表达EMMPRIN的影响[J].现代医学,2007,35(3):174-177. 被引量:3
  • 2Rrown B,Lindberg K,Reing J,et al.The basement membrane component of biologic Scaffolds derived from extracellular malrix[J] .Tissue Eng,2006,13(3):519-526.
  • 3Morin PJ, Sparks, KonJnek V, et al. Activation ofbeta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC[J]. Science,1997,275:1787-1790.
  • 4Vemeulen L,De Sottsa E,Melo F, et al.Wnt activity defines colon cancer stem cells and is regulated by the microenvironment[J].Net Cell Biol,2010,12(5):468-476.
  • 5Kououmkis MI,Gialromanolaki A, Harris AL, et al. Comparison of metabolic pathwangs bethwangs between cancer cells and slromal cells in colorectal carcinomas:a metabolic survival role for tumor associated slroma[J].Cancer Res,2006,66(2):632-637.
  • 6Bhowmick NA,Neilson EG,Moses HL.Slromal fibroblasls in cancer iniliation and Dvgression [J].Nature2004,432(7015):332-337.
  • 7Sappino AP, Schfirch W, Gabbiani G.Diffemntiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations[J].Lab Invest, 1990, 63(2): 144-161.
  • 8Nosho K,Yamamoto H,Taniguchi H,et al.Interplay of insulin- Like growth factor-II,insulin- Like growth factor- I ,insulin- Like growth factor- I receptor, COX-2,and matrix met alloproteinase-7, play key roles in the early stage of colorectal carcinogenesis[J]. Clin Cancer Res,2004,10(23):7950-7957.
  • 9Elainers E,Duval C, McCaiq C,et al.Insulin-Like growth factor binding protein-5 is a target of maVix metalloproteinase- 7:implications for epithelial-mesenchymal signaling[J]. Cancer Res,2005,65( 16):7363-7369.
  • 10Santos AM, Jung J, Aziz N, et al.Targeting fibroblast activation protein inhibits tumor strmagenesis and growth in mice[J].J Clin Invest2009,119(12):3613-3615.

共引文献1

同被引文献24

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部